In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

The eight new ACIP members met for the first time on June 25 after Kennedy fired all 17 original members of the committee on June 9.

Nearly three-quarters of infants were immunized against respiratory syncytial virus through maternal vaccination or ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness and death among children worldwide, particularly in children younger than 6 months and in low-income and ...

A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and ...

Most RSV symptoms resemble a common cold, so it can be hard to determine if an illness is the virus or not, the CDC says. Though most RSV cases are mild, the virus can develop into severe infections.